Medicare Enrolled
Dr. Ali Bukhari, M.D.
Hematology & Oncology · Dayton, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bukhari from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bukhari?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bukhari
Dr. Ali Bukhari is a hematology & oncology specialist in Dayton, OH, with 13 years of NPI registration. Based on federal Medicare data, Dr. Bukhari performed 1,046 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bukhari received a total of $3,417 from 43 pharmaceutical and/or device companies across 92 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bukhari is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years of NPI registration
▲ Top 32% volume in OH
$3,417 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,046
Medicare services
Top 32% in OH for hematology & oncology
Not available
Unique patients (not deduplicated)
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
260 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 230 | $1 | $122 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
132 | $8 | $35 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
83 | $13 | $105 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
71 | $138 | $438 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
52 | $113 | $686 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
42 | $12 | $91 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
38 | $25 | $152 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $75 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $107 | $327 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
28 | $55 | $334 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
21 | $2 | $19 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
17 | $55 | $304 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
14.9% high complexity
58.8% medium
26.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,417
Total received (2018-2024)
Avg $488/year across 7 years
Top 46% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
92
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,468
2023
$85
2022
$369
2021
$274
2020
$24
2019
$725
2018
$471
Payments by company (2024)
PFIZER INC.
$178
Novartis Pharmaceuticals Corporation
$128
Daiichi Sankyo Inc.
$112
E.R. Squibb & Sons, L.L.C.
$103
GlaxoSmithKline, LLC.
$81
ABBVIE INC.
$80
AstraZeneca Pharmaceuticals LP
$58
Incyte Corporation
$46
Lilly USA, LLC
$40
Genentech USA, Inc.
$38
Invivyd Inc
$35
GENZYME CORPORATION
$34
PharmaEssentia USA Corporation
$34
Merck Sharp & Dohme LLC
$33
JAZZ PHARMACEUTICALS INC.
$32
Bayer Healthcare Pharmaceuticals Inc.
$30
EMD Serono, Inc.
$29
Takeda Pharmaceuticals U.S.A., Inc.
$28
Aveo Pharmaceuticals, Inc.
$28
Ipsen Biopharmaceuticals, Inc
$26
BeiGene USA, Inc.
$25
Eisai Inc.
$25
Spectrum Pharmaceuticals Inc.
$22
Astellas Pharma US Inc
$21
TerSera Therapeutics LLC
$21
Blueprint Medicines Corporation
$21
Azurity Pharmaceuticals, Inc.
$21
Pharmacosmos Therapeutics Inc.
$20
ADC Therapeutics America, Inc.
$20
SOBI, INC
$19
Gilead Sciences, Inc.
$18
Regeneron Healthcare Solutions, Inc.
$16
Celgene Corporation
$16
Janssen Biotech, Inc.
$15
Acrotech Biopharma Inc.
$14
Top 3 companies account for 28.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$976
E.R. Squibb & Sons, L.L.C.
$249
Janssen Biotech, Inc.
$235
PFIZER INC.
$190
Pharmacyclics LLC, An AbbVie Company
$148
JAZZ PHARMACEUTICALS INC.
$130
Novartis Pharmaceuticals Corporation
$128
Bayer HealthCare Pharmaceuticals Inc.
$117
Daiichi Sankyo Inc.
$112
AstraZeneca Pharmaceuticals LP
$110
GlaxoSmithKline, LLC.
$81
ABBVIE INC.
$80
Merck Sharp & Dohme LLC
$62
Incyte Corporation
$61
Lilly USA, LLC
$40
Genentech USA, Inc.
$38
Adaptive Biotechnologies Corporation
$36
Invivyd Inc
$35
GENZYME CORPORATION
$34
Foundation Medicine, Inc.
$34
PharmaEssentia USA Corporation
$34
Celgene Corporation
$31
Bayer Healthcare Pharmaceuticals Inc.
$30
EMD Serono, Inc.
$29
Takeda Pharmaceuticals U.S.A., Inc.
$28
Aveo Pharmaceuticals, Inc.
$28
Ipsen Biopharmaceuticals, Inc
$26
BeiGene USA, Inc.
$25
Eisai Inc.
$25
Spectrum Pharmaceuticals Inc.
$22
Astellas Pharma US Inc
$21
TerSera Therapeutics LLC
$21
Blueprint Medicines Corporation
$21
Azurity Pharmaceuticals, Inc.
$21
Pharmacosmos Therapeutics Inc.
$20
Coherus Biosciences Inc.
$20
ADC Therapeutics America, Inc.
$20
SOBI, INC
$19
Gilead Sciences, Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Regeneron Healthcare Solutions, Inc.
$16
EISAI INC.
$15
Acrotech Biopharma Inc.
$14
Top 3 companies account for 42.7% of all-time payments
Associated products mentioned in payments ›
ALUNBRIG · AUGTYRO · AYVAKIT · BELEODAQ · BESREMI · BOSULIF · Blincyto · CALQUENCE · DEFITELIO · DOPTELET · Enhertu · FOTIVDA · FOUNDATIONONE · Fabhalta · GILOTRIF · IBRANCE · IMBRUVICA · IMLYGIC · Imbruvica · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LUMAKRAS · Lenvima · MONJUVI · MONOFERRIC · Nplate · Nubeqa · OJJAARA · OPDIVO · Onivyde · PADCEV · PEMGARDA · PLUVICTO · PREVNAR 13 · Padcev · Perjeta · Quzyttir · ROLVEDON · RYBREVANT · Revlimid · SARCLISA · TEVIMBRA · TIVDAK · TUKYSA · Udenyca · VENCLEXTA · VERZENIO · VIVIMUSTA · Venclexta · Vitrakvi · XGEVA · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
38
County median income
$85,218
Nearest hospital to ZIP centroid (approximate)
88th Medical Group (Wright-Patterson AFB)
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bukhari is a mixed practice specialist, with moderate Medicare volume.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bukhari experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Bukhari performed 260 dexamethasone injection (steroid) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bukhari receive payments from pharmaceutical companies?
Yes. Dr. Bukhari received a total of $3,417 from 43 companies across 92 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bukhari's costs compare to other hematology & oncology specialists in Dayton?
Dr. Bukhari's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bukhari) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Dayton
Browse hematology & oncology specialists in Dayton ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology